The c-abl tyrosine kinase is the proto-oncogene of the vabl oncogene of the Abelson murine leukemia virus. Although mutational variants of c-Abl can exhibit gain of function and can produce a transformed phenotype, the function of c-Abl in transformation remained unclear. Here, we report that the loss of c-abl facilitates transformation. c-abl-knockout mouse embryonic fibroblasts (MEFs) immortalized by SV40 T antigen acquired anchorage-independent growth, and by constructing mutational variants of T antigen we showed that binding of large T antigen to p53 and RB was necessary to induce anchorage-independent growth. Although c-abl/p53 double-knockout MEFs did not undergo anchorage-independent growth, those expressing human papilloma virus 16 E7, which mainly inactivates RB, did. Our results show that the loss of c-abl facilitates anchorage-independent growth in the context of p53 and RB deficiency, and suggest that loss of function of c-abl facilitates some types of transformation.
Introduction c-abl is the proto-oncogene of the v-abl oncogene of the Abelson murine leukemia virus and encodes a nonreceptor tyrosine kinase (Goff et al., 1980) . The Abelson murine leukemia virus is known to induce a pre-B-cell leukemia in mice (Abelson and Rabstein, 1970) , but the cellular function of c-Abl in transformation remains unknown. Although c-Abl overexpression negatively regulates cell growth (Sawyers et al., 1994) , fibroblasts from c-abl-knockout mice show slower growth in the context of p53 deficiency (Whang et al., 2000) . Kinase activity is necessary for the physiological function of c-Abl (Hardin et al., 1996) .
The kinase activity of c-Abl is restricted by intramolecular folding of the N-terminus onto the kinase domain Nagar et al., 2003) , or by trans-acting inhibitor molecules (Pendergast et al., 1991; Shishido et al., 2000; Smith and Mayer, 2002) . Our group recently showed that other trans-acting adaptor molecules can activate the inhibited c-Abl kinase (Shishido et al., 2001; Tani et al., 2003) , probably regulating substrate phosphorylation by inducing conformational changes in both the kinase and the substrate (Shishido et al., 2000; Shishido et al., 2001; Tani et al., 2003) . This model led us to identify mammalian Enabled (Mena) (Gertler et al., 1996) , whose Drosophila homologue was shown by a genetic approach to interact with c-Abl (Gertler et al., 1995) , as an efficient substrate of c-Abl. Mena and c-Abl are involved in cytoskeleton reorganization (Bear et al., 2000; Woodring et al., 2003) . Cytoskeletal changes are important for the anchorageindependent growth of transformed cells (Pawlak and Helfman, 2001 ), but little is known about the contribution of c-Abl to the cytoskeletal changes associated with anchorage-independent growth.
Anchorage-independent growth is one of the most prominent phenotypes that characterize tumor cells in vitro (Jove and Hanafusa, 1987) . Anchorage-independent growth and immortalization of murine primary fibroblasts by SV40 T antigen have been extensively studied (Jat and Sharp (1986) ; reviewed in Ali and DeCaprio, 2001; Pipas and Levine, 2001 ). SV40 T antigen consists of large T antigen (LT) and small T antigen (ST) (Rundell and Parakati, 2001) . LT specifically binds and inactivates p53 (Lane and Crawford, 1979) and RB (DeCaprio et al., 1988) , and has been shown to be necessary for immortalization and anchorage-independent growth of primary fibroblasts. ST reportedly binds to PP2A phosphatase (Pallas et al., 1990) , and was recently shown to promote the transformed phenotype when combined with LT in human cells (Hahn et al., 2002) .
In this study, we found that c-abl-knockout mouse embryonic fibroblasts (MEFs) immortalized by SV40 T antigen facilitated anchorage-independent growth in soft agar. We dissected the function of T antigen to examine its role in c-abl-knockout MEFs. We found that expression of LT alone was sufficient to confer anchorage-independent growth. We also analysed c-abl/ p53 double-knockout MEFs. Although c-abl/p53 double-knockout MEFs did not show anchorage-independent growth, additional expression of human papilloma virus (HPV) 16 E7 protein, which mainly inactivates RB protein, led to anchorage-independent growth in these cells. Our observations suggest that not only gain of function but also loss of function of c-abl can contribute to cellular transformation in the context of p53 and RB deficiency.
Results

Immortalization by SV40 T antigen promotes anchorageindependent growth in c-abl-knockout MEFs
To study the cellular functions of c-abl in a primary population of cells, rather than in immortalized cell lines, we artificially immortalized c-abl knockout (À/À) and wild-type ( þ / þ ) primary MEFs by introducing retrovirus expressing SV40 T antigen (Akagi et al., 2003) . Immortalized c-abl(À/À) MEFs grew more slowly than immortalized c-abl( þ / þ ) MEFs in the context of p53 deficiency, in this study by expressing T antigen, as published (Whang et al., 2000) (data not shown). Since expression of T antigen is sufficient for some murine cells to acquire anchorage-independent growth (Weinberg, 1985) , we examined whether c-abl( þ / þ ) and (À/À) MEFs expressing T antigen acquired anchorage independence, by performing a soft agar colony formation assay. The c-abl(À/À) MEFs immortalized by T antigen formed many colonies in soft agar, whereas the c-abl( þ / þ ) MEFs immortalized by T antigen formed fewer colonies ( Figure 1a) ; colonies formed by c-abl(À/À) MEFs immortalized by T antigen were also larger than those formed by the c-abl( þ / þ ) MEFs (Figure 1b) . Three other c-abl(À/À) MEF populations, obtained from different mice, immortalized by T antigen also acquired anchorage-independent growth (data not shown), suggesting that anchorageindependent growth of c-abl(À/À) MEFs is not affected by genetic background.
To test whether the c-abl(À/À) fibroblasts might acquire anchorage independence in different immortalized state, we immortalized the MEFs by the 3T3 method (Todaro and Green, 1963) . However, neither the c-abl( þ / þ ) nor the c-abl(À/À) 3T3 MEFs formed colonies in soft agar (Figure 1c) . The levels of c-Abl, LT and ST expression were determined by Western blotting (Figure 1d ). These observations indicated that the loss of function of c-abl promoted anchorage-independent growth only in MEFs immortalized by SV40 T antigen.
Loss of c-Abl kinase activity is required for anchorageindependent growth of MEFs immortalized by T antigen
To verify that the phenotypes of c-abl(À/À) MEFs were due solely to the lack of c-Abl, we expressed a wild-type (WT) and a kinase-deficient (KD) mutant of c-abl in cabl(À/À) MEFs immortalized by T antigen. c-abl(À/À) MEFs expressing WT c-Abl formed fewer colonies while One explanation of these results could be that KD c-Abl acts as a dominant negative mutant of the endogenous cAbl kinase (Sawyers et al., 1994) , leading to loss of function of c-Abl and facilitating anchorage-independent growth of c-abl
LT is sufficient for anchorage-independent growth of c-abl (À/À) MEFs SV40 LT and ST are translated from alternatively spliced transcripts. ST enhances the transformation activity of LT (Bikel et al., 1987) , and recent studies have indicated that ST, by binding to phosphatase 2A
(PP2A), is essential for tumorigenic conversion of human cells (Hahn et al., 2002) . To investigate whether c-abl(À/À) MEFs require ST for the induction of anchorage independence, we constructed a mutant form of T antigen, named Tns (T antigen no small t), which expresses LT, but not ST due to deletion of the required splicing site (Figure 3a) . We transduced c-abl(À/À) MEFs with a retrovirus expressing Tns antigen, which was sufficient for the MEFs to be immortalized. c-abl(À/ À) MEFs expressing Tns antigen formed colonies in soft agar ( Figure 3b ). The number of small colonies increased, but the number of larger colonies decreased, compared to c-abl(À/À) MEFs expressing T antigen (Figure 1b and 3c). Levels of Tns antigen were confirmed by Western blot using anti-LT antibody ( Figure 3d ).
To confirm that lack of c-abl promoted anchorage independence in MEFs immortalized by Tns antigen, we introduced WT c-abl into the c-abl(À/À) MEFs immortalized by Tns antigen: these cells failed to form colonies (Figure 3b and c).
Binding of LT to RB and p53 is necessary for c-abl (À/À) MEFs to acquire anchorage independence
The transforming activity of LT is due in large part to the inactivation of the RB and p53 tumor suppressors (Hahn et al., 2002) . To define the domains of LT required for anchorage-independent growth of c-abl(À/À) MEFs, we constructed two well-characterized mutant forms of LT from the Tns vector. One, Tns G107S, contains an alteration in the RB consensus-binding motif and is consequently deficient in binding to RB (Kalderon and Smith, 1984) (Figure 4a) , and the other, Tns P584L, carries a substitution that renders its p53-binding domain nonfunctional (Peden et al., 1989) (Figure 4a ). We introduced these mutants into the cabl(À/À) MEFs and tested whether the MEFs could develop into colonies in soft agar. While MEFs immortalized by Tns G107S were relatively easy to culture, those immortalized by Tns P584L were not, and neither of them formed colonies in soft agar (Figure 4b and c). These observations indicate that binding to both p53 and RB is necessary for LT to induce anchorageindependent growth in c-abl(À/À) MEFs. From the above findings, we hypothesized that the loss of c-abl function could facilitate anchorage-independent growth of MEFs in conjunction with inactivation of p53 and RB. To test this hypothesis, we first prepared c-abl/ p53 double-knockout {c-abl(À/À) p53(À/À)} MEFs.
Male and female mice heterozygous for both p53 and cabl were mated to produce mice lacking both c-abl and p53. From day 16 mouse embryos, we obtained c-abl(À/ À) p53(À/À) MEFs, which are spontaneously immortalized and stable, and examined these MEFs for anchorage-independent growth using the colony formation assay. Although c-abl( þ / þ ) p53(À/À) and cabl(À/À) p53(À/À) MEFs are spontaneously immortalized, they did not form colonies in soft agar (Figure 5a ). We next introduced a retrovirus expressing HPV16 E7 into c-abl(À/À) p53(À/À) MEFs. Inactivation of RB was confirmed by Western blot using anti-RB antibody (Figure 5d ). To determine whether c-abl(À/À) p53(À/À) MEFs expressing E7 acquired anchorage independence, we performed the soft agar colony assay. c-abl(À/À) p53(À/À) MEFs expressing E7 formed many colonies, although these were much smaller than those of c-abl(À/ À) MEFs expressing Tns antigen (Figure 3c , 5b and c). Expression of E7 in c-abl(À/À) p53( þ / þ ) MEFs did not induce any colonies (Figure 5b and c) , but its expression in c-abl( þ / þ ) p53(À/À) MEFs induced a small number of colonies (Figure 5b and c). These observations suggest that the loss of function of c-abl promotes anchorage-independent growth of MEFs in the context of p53 and RB deficiency.
Loss of the c-Abl expression in human CML cell lines
We investigated several human leukemia cell lines for c-Abl expression by Western blotting using anti-Abl antibody (Figure 6 ). HL60 and Jurkat cells expressed c-Abl (Figure 6 ), but among several chronic Figure 5 Anchorage-independent growth of MEFs lacking cellular genes coexpressed with HPV16 E7. (a) Indicated MEFs at passage 3 were subjected to colony formation assay as described for Figure 1a. (b) Indicated MEFs at passage 3 were infected with a retrovirus expressing HPV16 E7. The drug-selected population of the indicated MEFs was applied to colony formation assay as described for Figure 1a . (c) Colonies were scored as described for Figure 1b (Figure 6 ). The K562 cells expressed both Bcr-Abl and c-Abl, but MEG01 and Ku812E cells expressed only Bcr-Abl. Our observations of c-abl(À/À) MEFs, as well as these two CML cell lines, support the idea that not only the activation of c-abl, in the bcr-abl oncogenic form, but also the loss of function of c-abl can accelerate transformation in these cells.
Discussion
Biological significance of the loss of c-abl in vitro
In this study, we investigated the function of c-abl in cellular transformation by establishing an efficient immortalization system using primary MEFs. Using a combination of mutant viral oncogenes and genetically manipulated primary MEFs, we found that the loss of function of c-abl facilitated anchorage-independent growth of MEFs immortalized by SV40 T antigen. While these results suggest that c-Abl suppresses anchorage-independent growth of MEFs, c-abl(À/À) MEFs showed a reduced growth rate in the context of p53 and RB deficiency, indicating that c-Abl positively regulates the cell growth depending on the cellular status (Whang et al., 2000) . When we restored the expression of WT c-Abl in c-abl(À/À) MEFs immortalized by T antigen, these MEFs yielded fewer colonies, suggesting that c-Abl negatively regulates anchorage-independent growth. Preliminary data suggested that the reintroduction of c-Abl into c-abl(À/À) MEFs immortalized by T antigen moderated growth during the first few passages, but accelerated growth as the passage number increased. Therefore, we will need to examine the effects of overexpression of c-Abl in greater details.
We have shown that the LT is sufficient to induce anchorage-independent growth of c-abl(À/À) MEFs. MEFs lacking both c-abl and p53 did not induce colonies in soft agar. However, additional expression of HPV16 E7, which inactivates RB, in these doubleknockout MEFs did induce colonies in soft agar. This result suggests that the loss of c-abl facilitates anchorage-independent growth in the context of p53 and RB deficiency. Colony formation in the c-abl/p53 doubleknockout MEFs expressing E7 was weaker than in cabl(À/À) MEFs expressing LT, suggesting that LT not only inactivates p53 and RB but also targets other cellular pathways. These considerations may help to explain the differences in anchorage independence of cabl(À/À) MEFs due to deficiencies of cellular genes on the one hand and inactivation of cellular target proteins by viral oncoproteins on the other hand. It is possible that the HPV16 E7 oncoprotein used in our system binds to other proteins to enhance transformation, as well as inactivating the RB tumor suppressor as its major cellular target. Specific inactivation of RB by expression of dominant negative RB or RNAi method will be needed to show whether cellular gene deficiencies cooperate with the loss of c-abl to promote anchorageindependent growth.
How is anchorage independence negatively regulated by c-Abl? Recently, our group reported that c-Abl dramatically phosphorylates Mena when coexpressed with Abi-1 (Tani et al., 2003) . Mena is implicated in cell motility through regulation of the actin cytoskeleton (Gertler et al., 1996) , and has been reported that Abi-1 is involved in Rac-dependent cytoskeletal reorganization (Scita et al., 1999) . Abi-1 binds to Sos and inhibits EGFand v-Abl-induced activation of Erks (Fan and Goff, 2000) . It is possible that the c-Abl-Abi-1-Mena pathway constitutes a negative signal for anchorage independence. Moreover, cytoplasmic c-Abl-mediated disassembly of the Crk/CAS complex inhibits cell migration and promotes apoptosis via disruption of the cytoskeleton (Kain et al., 2003) . The combination of unregulated cytoskeleton signals in cytoplasm due to the loss of cAbl and nuclear events mediated by the loss of p53 and RB may be sufficient to induce MEFs to form colonies in soft agar. While the cellular machinery in attached cells has been well studied, little is known about suspended cells. Therefore, it will be very important to elucidate the cellular machinery of suspended cells when investigating the role of c-Abl in anchorage independence.
Biological significance of the loss of c-abl in vivo c-abl knockout and mutant mice display similar phenotypes such as runtedness, splenic and thymic atrophy, and reduced B and T lymphocytes; almost all of them die 1-2 weeks after birth (Schwartzberg et al., 1991; Tybulewicz et al., 1991) . Our observation that the loss of c-abl facilitated anchorage-independent growth, one of the most prominent phenotypes of tumor cells (Jove and Hanafusa, 1987) , raises the question of whether c-abl knockout mice are susceptible to tumor formation. However, the latent period of c-abl knockout mice is likely to be too short for accumulating mutations to develop tumor because our experiments in vitro suggest that loss of c-abl facilitates anchorage-independent growth at least in the context of inactivation of p53 and RB. c-abl/p53 double-knockout mice are also not viable (Whang et al., 2000) .
Loss of c-Abl expression in CML cell lines
We found that expression of c-Abl protein was lost in some CML lines established from blast crisis patients. Although methylation of the c-abl proximal promoter has been associated with disease progression (Zion et al., 1994; Issa et al., 1999) , prognostic value of such methylation needs further investigation (Asimakopoulos et al., 1999) . Our study suggests that the level of c-Abl expression could also be associated with CML disease progression. To test this idea, c-Abl expression should be monitored in cell lines established from the same patients before and after the blast crisis phase, in conjunction with Northern blot analysis to determine whether c-abl mRNA correlates with protein expression. Our results also indicate that while the gain of function of c-Abl, in Bcr-Abl oncogenic form, may contribute to cell growth by the activation of positive signaling pathways, the loss of c-Abl function may also contribute to anchorage independence. Overexpression of c-Cbl, a known substrate of c-Abl (Shishido et al., 2000; Miyoshi-Akiyama et al., 2001) , suppresses anchorage-independent growth of v-Abl-transformed NIH3T3 fibroblasts (Feshchenko et al., 1999) , suggesting that cAbl activation and c-Cbl normally suppresses anchorage-independent growth. Loss of function of c-Abl may thus contribute to anchorage independence by deregulating the pathways involving Abi-1, c-Crk, c-Cbl and other adaptor proteins. Although it remains to be elucidated which c-Abl substrates might be involved, our study raises the possibility that the loss of function of c-abl can facilitate some types of transformation.
Materials and methods
Plasmid construction
Tns antigen, which expresses LT, but not ST, was constructed by PCR using pZipneoSV40 T antigen (Jat and Sharp, 1986) as a template and Pfu polymerase (Stratagene). First 5 0 region of LT was amplified using primers ggatccagatggataaagttttaaacagagag and ccataggttggaatctcagttgcatcccagaagcct, and the 3 0 region was amplified using primers ggatgcaactgagattccaacctatggaactgatgaat and ggatccttatgtttcaggttcaggttcagggggag. Both fragments were mixed and amplified using primers ggatccagatggataaagttttaaacagagag and ggatccttatgtttcaggttcaggttcagggggag. Full-length Tns was cloned into pCRBlunt (Invitrogen) and sequenced. Mutations were introduced using a Quick Change site-directed mutagenesis kit (Stratagene) to make the RB-binding mutant Tns G107S (Kalderon and Smith, 1984) and the p53-binding mutant Tns P584L (Peden et al., 1989) . The BamHI fragments of SV40 T antigen, Tns antigen and two mutants, Tns G107S and Tns P584L, were subcloned into the BamHI site of the pCX4puro vector (Akagi et al., 2003) .
The BamH1 fragments of HPV16 E7 were subcloned into the pCX4bsr vector. WT and KD c-Abl (K290M) (a gift from David Baltimore) were subcloned into pCX4bsr.
Cells
HL60 and Jurkat cells were gifts from Stephan Feller. K562(CCL-243) and MEG01(IFO50151) were obtained from ATCC. Ku812E(JCRB0104.1) was obtained from the Japan Health Science Foundation. These human leukemia cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS) and antibiotics.
Primary fibroblast preparation
Day 16 MEFs lacking c-abl were prepared from mated c-abl heterozygous mice (Tybulewicz et al., 1991 ) (a gift from Richard Mulligan). p53 knockout mice (Donehower et al., 1992) were purchased from Taconics Inc. with a crossbreeding agreement at Osaka Bioscience Institute and Nara Institute of Science and Technology. Day16 MEFs lacking both c-abl and p53, as well as p53 knockout MEFs were obtained by crossbreeding mice carrying heterozygous mutations in both c-abl and p53. c-abl and p53 genotyping was performed by PCR using tail genomic DNA. c-abl( þ / þ ) and (À/À) 3T3 fibroblast lines were generated according to the 3T3 method (Todaro and Green, 1963) . The primary fibroblasts were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS and antibiotics.
Retroviral infections and isolation of stable infected cells
To prepare recombinant retroviruses, we transfected the pCX vector, incorporating the appropriate genes, into Platinum-E cells (a gift from Toshio Kitamura) (Morita et al., 2000) using Fugene 6 transfection reagent (Boehringer Mannheim). After 48 h, the supernatant were collected and filtered through a 0.45 mm pore-size filter before infection of primary fibroblasts at passages 3-5. These experiments were performed at the Institute of Microbial Diseases, Osaka University (courtesy of Masuo Yutsudo). At 24 h after infection, the supernatant was replaced with new medium, and infected cells expressing each protein were selected by puromycin for pCX4puro vector or blasticidin S for pCX4bsr vector.
Soft agar colony formation assay
Primary cells expressing viral oncogenes were prepared to use for colony formation assay at passages 2-5 after selection. Cells were washed with phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.47 mM KH 2 PO 4 ) and separated from attaching cells by 0.05% Trypsin in PBS to isolate single cells. For the colony formation assay, 5 Â 10 4 of the cells were inoculated on 6-cm culture dishes as described previously (Akagi et al., 2003) . Each culture dish was incubated for 18 days at 351C, and photographed after staining with 1 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Sigma) in PBS. Colonies were examined under a light microscope and counted after capturing images by scanner.
Western blotting
Cells were lysed in lysis buffer (1% Triton X-100, 10 mM TrisHCl pH 7.6, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 20 mM b-glycerophosphate, 1 mM EDTA, 1 mM EGTA, 1 mM sodium vanadate, 20 mg/ml aprotinin, 1 mM phenylmethylsulphonyl fluoride). The lysates were analysed by 8-14% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto Immobilion-P membrane filters (Millipore). The membranes were blocked with 5% skim milk TBST (50 mM Tris pH7.6, 137 mM NaCl, 0.1% Tween 20) or 0.2% I-block (Tropix) and then incubated with primary antibody. After incubation with secondary antibody, the complexes were visualized with ECL plus enhanced chemiluminescence solutions (Amersham). Blocking and incubation with anti-LT (Pharmingen pAB101) and anti-b-actin (Sigma Ac-74) antibodies were performed in 5% skim milk. Anti-c-Abl (Pharmingen 8E9), anti-RB (Pharmingen G3-245) and anti-ST (Oncogene Research pAb280) were incubated in 0.2% I-Block TBST.
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